Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross I Baker

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Blood Advances|September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusionHelen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndromeHelen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunctionHelen Fogarty, Soracha E Ward, Liam Townsend, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectivesAmaury L L Monard, Caroline M A Mussert, Tirsa T van Duijl, et al.
Blood|June 23, 2016
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia AJohnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, et al.
Blood|December 24, 2023
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesFerdows Atiq, Robin Blok, Calvin B van Kwawegen, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Blood Advances|September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusionHelen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndromeHelen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunctionHelen Fogarty, Soracha E Ward, Liam Townsend, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectivesAmaury L L Monard, Caroline M A Mussert, Tirsa T van Duijl, et al.
Blood|June 23, 2016
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia AJohnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, et al.
Blood|December 24, 2023
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesFerdows Atiq, Robin Blok, Calvin B van Kwawegen, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 6